Rocket Lab Shares Garner Bullish Outlook on Wall Street

Analysts upgrade Rocket Lab to Outperform with $85 target, citing a $1.85B contract backlog, a major SDA satellite deal, and strategic acquisition of Mynaric.

A significant analyst upgrade and a substantial contract backlog are fueling a positive reassessment of Rocket Lab's market position. The company is increasingly viewed not just as a launch provider, but as a comprehensive space systems integrator, with its strategic moves in the defense sector drawing particular attention.

Analyst Upgrade Signals Confidence

On April 7, 2026, analysts at Citizens JMP upgraded their rating on Rocket Lab from "Market Perform" to "Outperform," establishing a price target of $85 per share. This reassessment reflects growing conviction in the firm's strategic direction within the aerospace and defense industry. Although the shares currently trade around €57.00, approximately 7% lower than their level a month prior, the analysts see considerable upside potential driven by the company's evolving business model.

A Foundation of Firm Contracts

Central to this optimistic view is a robust backlog of orders totaling approximately $1.85 billion. A dominant portion of this figure stems from defense-related programs. Notably, this includes a major $1.3 billion contract awarded by the Space Development Agency (SDA) for the delivery of satellite constellations.

Strategic Acquisition Receives Green Light

A key development for Rocket Lab's future capabilities is its pending acquisition of Germany's Mynaric AG. Regulatory approval from German authorities for the $75 million deal has now been secured, with finalization expected before the end of April 2026. The integration of Mynaric's laser communication technology is intended to enhance Rocket Lab's vertical integration and fortify its internal supply chain.

While the acquisition is seen as a necessary step to reduce reliance on external suppliers, questions remain about its sufficiency in securing long-term technological independence for complex SDA satellite constellations. The coming months will be crucial in observing how smoothly the integration of the new Munich-based operations proceeds.

Financial Performance and Diversification

The company's 2025 financial results underscore its growth trajectory, with revenue climbing 38% to $602 million. Rocket Lab is successfully diversifying its revenue streams beyond traditional rocket launches. A growing focus includes specialized military testing services, evidenced by a $190 million contract for hypersonic test flights.

Key Data Points:
* New Price Target: $85 set by Citizens JMP
* Contract Backlog: ~$1.85 billion
* SDA Contract Value: $1.3 billion for satellites
* Mynaric Acquisition: Scheduled for completion in April 2026
* 2025 Revenue Growth: Up 38% to $602 million

Looking ahead, the development of the "Neutron" rocket program is viewed as a critical catalyst for the stock's future performance. Investor attention is also turning to the annual shareholder meeting scheduled for May 20, 2026, where votes on board composition and executive compensation are on the agenda.